Legal & General Group
PROK icon

Legal & General Group’s ProKidney PROK Stock Holding History

Legal & General Group’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,925
Closed -$9.57K – 3509
2025
Q1 		$9.57K Hold
10,925
– – ﹤0.01% 3180
2024
Q4 		$18.5K Hold
10,925
– – ﹤0.01% 3050
2024
Q3 		$21K Buy
10,925
+3,987
+57% +$9.05K ﹤0.01% 3027
2024
Q2 		$17.1K Buy
6,938
+2,933
+73% +$7.87K ﹤0.01% 3088
2024
Q1 		$6.57K Sell
4,005
-1,661
-29% -$2.44K ﹤0.01% 3266
2023
Q4 		$10.1K Sell
5,666
-20,456
-78% -$43.9K ﹤0.01% 3234
2023
Q3 		$120K Sell
26,122
-2,313
-8% -$22.1K ﹤0.01% 2808
2023
Q2 		$318K Buy
28,435
+19,435
+216% +$207K ﹤0.01% 2612
2023
Q1 		$102K Buy
9,000
+714
+9% +$7.6K ﹤0.01% 2771
2022
Q4 		$56.8K Buy
+8,286
New +$79.2K ﹤0.01% 2930

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Legal & General Group's PROK Position: Q2 2025 in Review

Legal & General Group sold out of ProKidney (PROK) in Q2 2025, closing a stake of 10,925 shares — an estimated $9.57K sold.

Legal & General Group first reported a position in PROK in Q4 2022 and held it in 10 quarters. The position peaked at $318K in Q2 2023. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2025.

  • Legal & General Group reported no remaining ProKidney position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 10,925 ProKidney shares in Q2 2025, an estimated $9.57K.
  • Legal & General Group first reported a position in ProKidney in Q4 2022 and held it in 10 quarters.
  • Legal & General Group's ProKidney position peaked at $318K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.